Skip navigation View an alternate layout of this website with limited styles and no horizontal scrolling


0 consumer reviews. Login to rate this product.

Picture of NEUROMONICS TINNITUS TREATMENT DEVICE - OASIS The Neuromonics Tinnitus Treatment Device - Oasis is designed for use by individuals with tinnitus. This device is approximately the size of a cell phone and is equipped with device with headphones. It delivers precisely designed music embedded with a pleasant acoustic neural stimulus. These sounds, customized for each user’s audiological profile, stimulate the auditory pathway to promote neural plastic changes. Over time, these new connections help the brain to filter out tinnitus disturbance, providing long-term relief from symptoms. During stage one, which lasts approximately two months and is intended to relive symptoms, the device is worn for at least two hours per day (longer, if preferred) during daily activities like reading, preparing meals, or at the office. Stage two lasts approximately four months, during which the brain is assisted in developing neural pathways, and the device is used for at least two hours per day initially. Treatment times are then gradually reduced as tinnitus disturbance lessens. Afterward, the audiologist will set a maintenance program for use.

Notes: Oasis is a trademark. ** The manufacturer states this device and treatment require a prescription. ** The manufacturer states this device is a FDA-cleared, patented, and clinically proven medical device.

Price: Contact manufacturer..

This product record was updated on December 31, 2012.

This product is available from:


Neuromonics Inc.

2810 Emrick Blvd.
Bethlehem, Pennsylvania 18020
United States
Telephone: 866-606-3876 or 484-821-1260.
Fax: 484-214-0166.

Link to more products from Neuromonics Inc.

AbleData, 103 W. Broad Street, Suite 400, Falls Church, VA 22046. 1-800-227-0216. Se habla español.
Maintained for the National Institute on Disability and Rehabilitation Research of the U.S. Dept. of Education
by New Editions Consulting under Contract No. ED-OSE-13-C-0064.

The records in AbleData are provided for information purposes only. Neither the U.S. Department of Education nor New Editions Consulting has examined, reviewed, or tested any product, device, or information contained in AbleData. The Department and New Editions Consulting make no endorsement, representation, or warranty express or implied as to any product, device, or information set forth in AbleData. The views expressed on this site do not necessarily represent the opinions of the Department of Education, the National Institute on Disability and Rehabilitation Research, or New Editions Consulting.